New study aims to map rare childhood brain disorder
NCT ID NCT07531511
First seen Jun 24, 2026 · Last updated Jul 31, 2026 · Updated 5 times
Summary
This study will follow 60 children with SLC6A1-NDD, a rare genetic condition causing seizures, developmental delays, and autism. Researchers will track symptoms like seizure frequency and development over time to better understand the disease. The goal is to gather information that could help design future treatment studies.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could provide the data needed to design future trials for treatments targeting SLC6A1-NDD.
- What could go wrong
- This is an observational study, not a treatment trial. It may not lead directly to new therapies, and results depend on participant engagement and data quality.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHIES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Gtep01 40131
RECRUITINGStrasbourg, France
-
Gtep01 40870
RECRUITINGMadrid, Spain
-
Gtep01 50614
RECRUITINGNew York, New York, 10021, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.